Discover open access scientific publications

Search, annotate, share and cite publications

Publications by David A. Hokey

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-Controlled, First-In-Human Phase 1 Trial

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Immune Modulation Through 4-1bb Enhances SIV Vaccine Protection in Non-Human Primates Against SIVmac251 Challenge

PLoS ONE
Multidisciplinary
2011English

Related publications

First-In-Human Phase 1 Trial of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 5 HVR48 (rAd5HVR48) HIV-1 Vaccine

Retrovirology
VirologyInfectious Diseases
2012English

Phase 1 Safety and Immunogenicity Trial of Recombinant Lactococcus Lactis Expressing Human Papillomavirus Type 16 E6 Oncoprotein Vaccine in Healthy Females

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2019English

Safety and Immunogenicity of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine in Healthy Adults in Sierra Leone: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial

The Lancet
Medicine
2017English

A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2015English

Development of a Novel Recombinant BCG for Tuberculosis Vaccine

Japanese Journal of Leprosy
DermatologyMedicineInfectious Diseases
2013English

Safety and Immunogenicity of Novel Recombinant BCG and Modified Vaccinia Virus Ankara Vaccines in Neonate Rhesus Macaques

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2010English

Identification of DNA Methylation Patterns Predisposing for an Efficient Response to BCG Vaccination in Healthy BCG-naïve Subjects

Epigenetics
Cancer ResearchMedicineMolecular Biology
2019English

Safety and Immunogenicity of a mRNA-based Chikungunya Vaccine in a Phase 1 Dose-Ranging Trial

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

A Phase III Clinical Trial to Evaluate the Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Healthy Children, Adults, and Elderly

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy